Accipiter Biosciences

Biotechnology

Designs proteins that can act on multiple biological targets for drug development.

Source
Reported stage
Seed
Local presence
Seattle

$10.5M seed top-up reported July 31, 2026, following $12.7M at launch.

Research snapshot: 2026-11-01. Funding may have changed since the linked report.